Corpus Intelligence IC Memo — WINSTON MEDICAL CENTER 2026-04-26 18:59 UTC
IC Memo — WINSTON MEDICAL CENTER
Investment Committee Memorandum | MS | 14 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

WINSTON MEDICAL CENTER

CCN 250027 | WINSTON, MS | 14 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

WINSTON MEDICAL CENTER is a 14-bed rural/critical access in WINSTON, MS with $24.4M in net patient revenue and a -22.6% operating margin. The hospital serves a payer mix of 66.1% Medicare, 3.4% Medicaid, and 30.5% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -22.6% to -15.2% (+736bps).

Net Revenue HCRIS$24.4M
Current EBITDA COMPUTED$-5.5M
Operating Margin COMPUTED-22.6%
Occupancy HCRIS19.6%
Revenue / Bed COMPUTED$1.7M
Net-to-Gross HCRIS56.4%
Distress Probability ML58.4%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
43
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -22.6% places it below the state median. Among 43 size-comparable peers (7-28 beds), the median margin is -14.4%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (7-28), prioritizing same-state peers. 43 hospitals in the comp set.

HospitalStateBedsRevenueMargin
WINSTON MEDICAL CENTER (Target)MS14$24.4M-22.6%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
S.E. LACKEY MEMORIAL HOSPITALMS25$34.1M-2.1%
COVINGTON COUNTY HOSPITALMS25$33.7M-26.3%
PANOLA MEDICAL CENTERMS21$33.4M-21.8%
LAIRD HOSPITALMS25$31.4M-9.0%
TALLAHATCHIE CRITICAL ACCESS HMS18$30.9M-6.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$511K+210bp18mo
Cost to Collect4.5%2.5%$487K+200bp12mo
Denial Rate Reduction12.0%6.5%$482K+198bp12mo
A/R Days Reduction5200.0%3800.0%$296K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$511K
Cost to Collect
$487K
Denial Rate Reduction
$482K
A/R Days Reduction
$296K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$-5.5M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$-3.7M
Current Margin-22.6%
Pro Forma Margin-15.2%
WC Released (1x)$934K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-8.5M$-18.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-8.5M$-22.9M0.00x-100.0%
Bull Case9.0x11.0x$-7.6M$-19.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-7.6M$-23.8M0.00x-100.0%
Bear Case11.0x10.0x$-9.3M$-24.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-9.3M$-30.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumHeavy Medicare dependenceMedicare comprises 66.1% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 19.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 58.4% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 43 hospitals with 7-28 beds
  • Same-state prioritization (n=45)
  • Comp margins: P25=-24.7% / P50=-14.4% / P75=-7.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.